Literature DB >> 2645146

The effects of spiramycin on plasma cyclosporin A concentrations in heart transplant patients.

R Guillemain1, E Billaud, G Dreyfus, C Amrein, M Kitzis, V A Jebara, C Kreft-Jais.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2645146     DOI: 10.1007/bf00561034

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


× No keyword cloud information.
  7 in total

1.  Spiramycin does not increase plasma cyclosporin concentrations in renal transplant patients.

Authors:  M Kessler; P Netter; M Zerrouki; E Renoult; P Trechot; B Dousset; B Jonon; J M Mur
Journal:  Eur J Clin Pharmacol       Date:  1988       Impact factor: 2.953

2.  Effect of josamycin on plasma cyclosporine levels.

Authors:  C Kreft-Jais; E M Billaud; C Gaudry; J Bedrossian
Journal:  Eur J Clin Pharmacol       Date:  1987       Impact factor: 2.953

3.  Erythromycin enhances the absorption of cyclosporin.

Authors:  S K Gupta; A Bakran; R W Johnson; M Rowland
Journal:  Br J Clin Pharmacol       Date:  1988-03       Impact factor: 4.335

4.  Effect of erythromycin on cyclosporine levels.

Authors:  R J Ptachcinski; B J Carpenter; G J Burckart; R Venkataramanan; J T Rosenthal
Journal:  N Engl J Med       Date:  1985-11-28       Impact factor: 91.245

5.  [Pharmacokinetics and metabolism of cyclosporin; drug interactions].

Authors:  J F Le Bigot; D Lavene; J R Kiechel
Journal:  Nephrologie       Date:  1987

6.  Efficacy of intravenous spiramycin in the treatment of severe Legionnaires' disease.

Authors:  C Mayaud; E Dournon; V Montagne; M Denis; J Rossert; G Akoun
Journal:  J Antimicrob Chemother       Date:  1988-07       Impact factor: 5.790

7.  Cyclosporin-erythromycin interaction in normal subjects.

Authors:  D J Freeman; R Martell; S G Carruthers; D Heinrichs; P A Keown; C R Stiller
Journal:  Br J Clin Pharmacol       Date:  1987-06       Impact factor: 4.335

  7 in total
  5 in total

Review 1.  Pharmacokinetic drug interactions with cyclosporin (Part II).

Authors:  G C Yee; T R McGuire
Journal:  Clin Pharmacokinet       Date:  1990-11       Impact factor: 6.447

2.  Effect of ponsinomycin on cyclosporin pharmacokinetics.

Authors:  W Couet; B Istin; P Seniuta; D Morel; L Potaux; J B Fourtillan
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

3.  Interaction between roxithromycin and cyclosporin in heart transplant patients.

Authors:  E M Billaud; R Guillemain; N Fortineau; M D Kitzis; G Dreyfus; C Amrein; C Kreft-Jaïs; J M Husson; P Chrétien
Journal:  Clin Pharmacokinet       Date:  1990-12       Impact factor: 6.447

Review 4.  Macrolide antibacterials. Drug interactions of clinical significance.

Authors:  N A von Rosensteil; D Adam
Journal:  Drug Saf       Date:  1995-08       Impact factor: 5.606

Review 5.  Pharmacokinetic drug interactions of macrolides.

Authors:  P Periti; T Mazzei; E Mini; A Novelli
Journal:  Clin Pharmacokinet       Date:  1992-08       Impact factor: 6.447

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.